Literature DB >> 10712335

Predictors of improvements in daytime function outcomes with CPAP therapy.

R N Kingshott1, M Vennelle, C J Hoy, H M Engleman, I J Deary, N J Douglas.   

Abstract

Continuous positive airway pressure (CPAP) therapy improves daytime function in the sleep apnea/ hypopnea syndrome (SAHS) but it is unclear which patients benefit and what factors predict this improvement. To test the hypothesis that brief arousals from sleep predict improvements in daytime functioning with CPAP therapy, we prospectively studied 62 patients with polysomnography-defined SAHS. Each underwent daytime function assessments at baseline and after 6 mo of CPAP therapy to measure objective sleepiness, psychological well-being, quality of life, and cognitive performance. The microarousal frequency and AHI were poor predictors of improvements in daytime function with CPAP. Measures of hypoxemia predicted improvements in the mean sleep latency on the maintenance of wakefulness test, SAHS symptoms, quality of life, and reaction time, but such correlations were weak or moderate only explaining between 7% and 22% of variance. Significant relationships were found between CPAP use and improvements in self-ratings of daytime function. Results suggest that standard polysomnographic baseline variables are poor predictors of the response to CPAP therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712335     DOI: 10.1164/ajrccm.161.3.9905053

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  26 in total

1.  Randomized controlled trial of variable-pressure versus fixed-pressure continuous positive airway pressure (CPAP) treatment for patients with obstructive sleep apnea/hypopnea syndrome (OSAHS).

Authors:  Marjorie Vennelle; Sandra White; Renata L Riha; Tom W Mackay; Heather M Engleman; Neil J Douglas
Journal:  Sleep       Date:  2010-02       Impact factor: 5.849

Review 2.  Sleep . 6: obstructive sleep apnoea/hypopnoea syndrome and hypertension.

Authors:  G V Robinson; J R Stradling; R J O Davies
Journal:  Thorax       Date:  2004-12       Impact factor: 9.139

3.  Decisions, decisions, decisions.

Authors:  Rory Ramsey; Kingman P Strohl
Journal:  Sleep Breath       Date:  2005-12       Impact factor: 2.816

4.  Impact of microarousal associated with increased negative esophageal pressure in sleep-disordered breathing.

Authors:  Mayo Sukegawa; Akiko Noda; Yoshinari Yasuda; Seiichi Nakata; Tatsuki Sugiura; Seiko Miyata; Kumiko Honda; Yoshinori Hasegawa; Tsutomu Nakashima; Yasuo Koike
Journal:  Sleep Breath       Date:  2009-05-15       Impact factor: 2.816

5.  Can CPAP be indicated in adult patients with suspected obstructive sleep apnea only on the basis of clinical data?

Authors:  Carlos Alberto Nigro; Eduardo Dibur; María Rosario Aragone; Eduardo Borsini; Glenda Ernst; Facundo Nogueria
Journal:  Sleep Breath       Date:  2015-06-04       Impact factor: 2.816

6.  Factors influencing the response of psychological symptoms to continuous positive airway pressure therapy.

Authors:  Alicia Carissimi; Denis Martinez; Lenise J Kim; Cintia Z Fiori
Journal:  Sleep Breath       Date:  2013-11-27       Impact factor: 2.816

Review 7.  Sleep. 5: Driving and automobile crashes in patients with obstructive sleep apnoea/hypopnoea syndrome.

Authors:  C F P George
Journal:  Thorax       Date:  2004-09       Impact factor: 9.139

Review 8.  Pathophysiology of sleep apnea.

Authors:  Jerome A Dempsey; Sigrid C Veasey; Barbara J Morgan; Christopher P O'Donnell
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

9.  Brain white matter changes in CPAP-treated obstructive sleep apnea patients with residual sleepiness.

Authors:  Ying Xiong; Xiaohong Joe Zhou; Robyn A Nisi; Kelly R Martin; M Muge Karaman; Kejia Cai; Terri E Weaver
Journal:  J Magn Reson Imaging       Date:  2016-09-14       Impact factor: 4.813

10.  Oximetry alone versus portable polygraphy for sleep apnea screening before bariatric surgery.

Authors:  Maude Malbois; Vittorio Giusti; Michel Suter; Cyril Pellaton; Jean-Frédéric Vodoz; Raphael Heinzer
Journal:  Obes Surg       Date:  2010-01-06       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.